Prof Stephen Ackland MBBS, FRACP, GAICD
Professor Stephen Ackland is a Medical Oncologist based in Newcastle, Director of Hunter Cancer Research Alliance, and Editor-in-Chief of Asia Pacific Journal of Clinical Oncology. As a member of the Australian Institute of Company Directors since 2007, he has had roles on 3 not-for-profit boards (including Chairman, ANZBCTG 2015-2017, and 1 small biotech start-up). He has had many engagements with organisations and committees involved in cancer research, particularly clinical trials and in GI cancer.
In AGITG he was been a member of the SAC from 1995 – December 2018, and Chief Investigator on the Asymptomatic Metastatic Colorectal Cancer study (published 2005), co-investigator on the T3 rectal study (published 4 times), the MAX study (published twice), the GOFURTGO Study (published twice). He is currently the Australian Chief Investigator together with Michael Jameson (NZ), of the SPAR study, activated in early 2018. He is passionate about conducting gastrointestinal clinical trials efficiently and effectively, with timely activation and completion, and providing availability of infrastructure and clinical trials to Australasian oncologists.
AGITG Committee Positions
Member, Public Affairs, Marketing & Fundraising Committee
Member, Lower GI Working Party